204 related articles for article (PubMed ID: 32703157)
21. A novel liquid biopsy (NETest) identifies paragangliomas and pheochromocytomas with high accuracy.
Pacak K; Kidd M; Meuter L; Modlin IM
Endocr Relat Cancer; 2021 Oct; 28(11):731-744. PubMed ID: 34515661
[TBL] [Abstract][Full Text] [Related]
22. NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive.
Pavel M; Jann H; Prasad V; Drozdov I; Modlin IM; Kidd M
Neuroendocrinology; 2017; 104(2):170-182. PubMed ID: 27078712
[TBL] [Abstract][Full Text] [Related]
23. The clinical utility of circulating neuroendocrine gene transcript analysis in well-differentiated paragangliomas and pheochromocytomas.
Pęczkowska M; Cwikla J; Kidd M; Lewczuk A; Kolasinska-Ćwikła A; Niec D; Michałowska I; Prejbisz A; Januszewicz A; Chiarelli J; Bodei L; Modlin I
Eur J Endocrinol; 2017 Feb; 176(2):143-157. PubMed ID: 27913608
[TBL] [Abstract][Full Text] [Related]
24. NETest: A Systematic Review Focusing on the Prognostic and Predictive Role.
Puliani G; Di Vito V; Feola T; Sesti F; Centello R; Pandozzi C; Tarsitano MG; Verrico M; Lenzi A; Isidori AM; Giannetta E; Faggiano A
Neuroendocrinology; 2022; 112(6):523-536. PubMed ID: 34515175
[TBL] [Abstract][Full Text] [Related]
25. Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy.
Ćwikła JB; Bodei L; Kolasinska-Ćwikła A; Sankowski A; Modlin IM; Kidd M
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1437-45. PubMed ID: 26348352
[TBL] [Abstract][Full Text] [Related]
26. Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study.
van Treijen MJC; Korse CM; van Leeuwaarde RS; Saveur LJ; Vriens MR; Verbeek WHM; Tesselaar MET; Valk GD
Front Endocrinol (Lausanne); 2018; 9():740. PubMed ID: 30564197
[No Abstract] [Full Text] [Related]
27. NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis.
Malczewska A; Oberg K; Kos-Kudla B
Endocr Connect; 2021 Jan; 10(1):110-123. PubMed ID: 33289691
[TBL] [Abstract][Full Text] [Related]
28. Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.
Bodei L; Kidd M; Modlin IM; Severi S; Drozdov I; Nicolini S; Kwekkeboom DJ; Krenning EP; Baum RP; Paganelli G
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):839-851. PubMed ID: 26596723
[TBL] [Abstract][Full Text] [Related]
29. Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status.
Bodei L; Kidd M; Modlin IM; Prasad V; Severi S; Ambrosini V; Kwekkeboom DJ; Krenning EP; Baum RP; Paganelli G; Drozdov I
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1341-52. PubMed ID: 25947577
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity and Specificity of the NETest: A Validation Study.
Al-Toubah T; Cives M; Valone T; Blue K; Strosberg J
Neuroendocrinology; 2021; 111(6):580-585. PubMed ID: 32615553
[TBL] [Abstract][Full Text] [Related]
31. The NETest: The Clinical Utility of Multigene Blood Analysis in the Diagnosis and Management of Neuroendocrine Tumors.
Modlin IM; Kidd M; Malczewska A; Drozdov I; Bodei L; Matar S; Chung KM
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):485-504. PubMed ID: 30098712
[TBL] [Abstract][Full Text] [Related]
32. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection.
Modlin IM; Drozdov I; Alaimo D; Callahan S; Teixiera N; Bodei L; Kidd M
Endocr Relat Cancer; 2014 Aug; 21(4):615-28. PubMed ID: 25015994
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
[TBL] [Abstract][Full Text] [Related]
34. A clinical perspective on gastric neuroendocrine neoplasia.
Lawrence B; Kidd M; Svejda B; Modlin I
Curr Gastroenterol Rep; 2011 Feb; 13(1):101-9. PubMed ID: 21080245
[TBL] [Abstract][Full Text] [Related]
35. Biodistribution and first clinical results of
Ilhan H; Lindner S; Todica A; Cyran CC; Tiling R; Auernhammer CJ; Spitzweg C; Boeck S; Unterrainer M; Gildehaus FJ; Böning G; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Bartenstein P
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):870-880. PubMed ID: 31492994
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection.
Laskaratos FM; Liu M; Malczewska A; Ogunbiyi O; Watkins J; Luong TV; Mandair D; Caplin M; Toumpanakis C
Endocrine; 2020 Aug; 69(2):430-440. PubMed ID: 32291735
[TBL] [Abstract][Full Text] [Related]
37. The added value of
Kazmierczak PM; Rominger A; Wenter V; Spitzweg C; Auernhammer C; Angele MK; Rist C; Cyran CC
Eur Radiol; 2017 Apr; 27(4):1676-1684. PubMed ID: 27436022
[TBL] [Abstract][Full Text] [Related]
38. Gastric neuroendocrine neoplasms.
Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
[TBL] [Abstract][Full Text] [Related]
39. NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance.
van Treijen MJC; Korse CM; Verbeek WH; Tesselaar MET; Valk GD
Endocr Connect; 2022 Oct; 11(10):. PubMed ID: 35951312
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological features of primary gastric neuroendocrine neoplasms: A single-center analysis.
Xu TM; Wang CS; Jia CW; Qian JM; Li JN
J Dig Dis; 2016 Mar; 17(3):162-8. PubMed ID: 26860897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
